SIRT1 showed high nuclear expression in patient samples of Hodgkin’s lymphoma; once evaluated together with FOXP3 expression, SIRT1 inhibition can decrease the actions of T-reg cells [53]. The gene discussed is FOXP3; the disease is Hodgkins lymphoma.